EP1444976A1 — Buccal, polar and non-polar spray or capsule
Assigned to Flemington Pharmaceutical Corp · Expires 2004-08-11 · 22y expired
What this patent protects
Buccal aerosol sprays or capsule using polar and non-polar solvent have now been developed which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect. The buccal polar compositions of the invention comprises: aqueou…
USPTO Abstract
Buccal aerosol sprays or capsule using polar and non-polar solvent have now been developed which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect. The buccal polar compositions of the invention comprises: aqueous polar solvent 30-99.89%, active compound 0.001-60%, optionally flavoring agent 0.1-10%, and optionally propellant 2-10%.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.